HKD 1.7
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.42 Billion CNY | -5.85% |
2022 | 2.57 Billion CNY | -1.34% |
2021 | 2.6 Billion CNY | 112.41% |
2020 | 1.22 Billion CNY | 121.32% |
2019 | 554.21 Million CNY | 214.42% |
2018 | 176.26 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.38 Billion CNY | 0.0% |
2024 Q1 | 2.38 Billion CNY | -1.46% |
2023 Q4 | 2.42 Billion CNY | 0.0% |
2023 FY | 2.42 Billion CNY | -5.85% |
2023 Q3 | 2.42 Billion CNY | -4.61% |
2023 Q2 | 2.53 Billion CNY | 0.0% |
2023 Q1 | 2.53 Billion CNY | -1.29% |
2022 Q4 | 2.57 Billion CNY | 0.0% |
2022 Q1 | 2.58 Billion CNY | -0.93% |
2022 Q2 | 2.58 Billion CNY | 0.0% |
2022 FY | 2.57 Billion CNY | -1.34% |
2022 Q3 | 2.57 Billion CNY | -0.4% |
2021 Q1 | 2.81 Billion CNY | 129.41% |
2021 FY | 2.6 Billion CNY | 112.41% |
2021 Q2 | 2.81 Billion CNY | 0.0% |
2021 Q4 | 2.6 Billion CNY | 0.0% |
2021 Q3 | 2.6 Billion CNY | -7.41% |
2020 FY | 1.22 Billion CNY | 121.32% |
2020 Q4 | 1.22 Billion CNY | 0.0% |
2020 Q1 | - CNY | -100.0% |
2019 Q4 | 554.21 Million CNY | 0.0% |
2019 FY | 554.21 Million CNY | 214.42% |
2018 FY | 176.26 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -490.338% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 78.481% |